Buy & Sell Nuvalent Inc (NUVL) – Nuvalent Inc Price Today
Aura AI Summary
Key Stats
- $9.76BMarket Cap
- TechnologySector
- -19.84%3M Drawdown
- $8.48BEnterprise Value
- -Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 6 daysTypical Hold Time
Nuvalent Inc (NUVL) is currently valued at a market capitalization of $9.76B, with an enterprise value of $8.48B. Over the past 52 weeks, Nuvalent Inc has traded between a low of $72.16 and a high of $123.45, highlighting its annual price range. Over the past three months, Nuvalent Inc has recorded a drawdown of -19.84%, reflecting recent price volatility. On average, investors hold Nuvalent Inc for approximately 6 days, indicating typical investor behavior on the platform.
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Most Recent News
Roundtable to host webinar on new real-time AI/DeFi payment platform with Coinbase integration
RTB Digital, Inc. (Roundtable) announced a virtual investor webinar on June 26, 2026, to discuss its new real-time, onchain payment platform for professional media. The platform integrates Coinbase Prime and USDC payment rails, enabling instant ad re...

Bitget launches Stock+ enabling direct purchase of real US stocks with crypto assets.
Bitget has introduced Stock+, a new feature allowing users to buy real US stocks directly using USDC and other digital assets. This innovation bridges crypto and traditional finance by enabling stock ownership through a single platform without interm...

Man Group discloses 2.6% stake in DCC plc ahead of potential takeover moves.
Man Group PLC has disclosed an interest in 2.6% of DCC plc's ordinary shares, including direct ownership and derivatives, as per the Irish Takeover Panel rules. This disclosure signals a significant stake ahead of any potential takeover activity invo...
